Purification of infectious human herpesvirus 6A virions and association of host cell proteins

Virology Journal

Volumn 4, Issue , 2007, Pages

  Hammarstedt, Maria ^a   Ahlqvist, Jenny ^a   Jacobson, Steven ^b   Garoff, Henrik ^a   Fogdell Hahn, Anna ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CLATHRIN; EZRIN; IODIXANOL; MEMBRANE COFACTOR PROTEIN; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; VIRUS DNA; VIRUS PROTEIN; VIRUS RECEPTOR; CD46 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DNA DETERMINATION; HOST CELL; HUMAN HERPESVIRUS 6; HUMAN HERPEVIRUS 6A; MORPHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN CONTENT; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SILVER STAINING; VIRION; VIRUS PURIFICATION; WESTERN BLOTTING; CELL LINE; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; VIROLOGY;

HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6A;

ANTIGENS, CD46; BLOTTING, WESTERN; CELL LINE; DNA, VIRAL; HERPESVIRUS 6, HUMAN; HUMANS; MULTIPLE SCLEROSIS; VIRION;

EID: 37549055125     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-4-101     Document Type: Article

References (40)

1. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. K Yamanishi T Okuno K Shiraki M Takahashi T Kondo Y Asano T Kurata, Lancet 1988 1 1065 1067 10.1016/S0140-6736(88)91893-4 2896909
2. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. WR Drobyski KK Knox D Majewski DR Carrigan, N Engl J Med 1994 330 1356 1360 10.1056/NEJM199405123301905 8152447
3. Chronic myelopathy associated with human herpesvirus-6. IR Mackenzie DR Carrigan CA Wiley, Neurology 1995 45 2015 2017 7501151
4. Fulminant demyelinating encephalomyelitis associated with productive HHV-6 infection in an immunocompetent adult. LJ Novoa RM Nagra T Nakawatase T Edwards-Lee WW Tourtellotte ME Cornford, J Med Virol 1997 52 301 308 10.1002/(SICI)1096-9071(199707)52:3<301::AID-JMV11>3.0.CO;2-L 9210040
5. Case of fatal encephalitis by HHV-6 variant A. M Portolani M Pecorari MG Tamassia W Gennari F Beretti G Guaraldi, J Med Virol 2001 65 133 137 10.1002/jmv.2012 11505455
6. A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. T Stodberg Y Deniz N Esteitie B Jacobsson M Mousavi-Jazi H Dahl B Zweygberg Wirgart L Grillner A Linde, Neuropediatrics 2002 33 266 270 10.1055/s-2002-36739 12536370
7. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. ML Opsahl PG Kennedy, Brain 2005 128 516 527 10.1093/brain/awh390 15659422
8. Cytomegalovirus-induced CD13-specific autoimmunity - a possible cause of chronic graft-vs-host disease. C Soderberg S Larsson BL Rozell S Sumitran-Karuppan P Ljungman E Moller, Transplantation 1996 61 600 609 10.1097/00007890-199602270-00015 8610388
9. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients. C Soderberg S Sumitran-Karuppan P Ljungman E Moller, Transplantation 1996 61 594 600 10.1097/00007890-199602270-00014 8610387
10. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. JT Bechtel RC Winant D Ganem, J Virol 2005 79 4952 4964 15795281 10.1128/JVI.79.8.4952-4964.2005
11. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. E Chertova O Chertov LV Coren JD Roser CM Trubey JW Bess Jr. RC Sowder 2nd E Barsov BL Hood RJ Fisher K Nagashima TP Conrads TD Veenstra JD Lifson DE Ott, J Virol 2006 80 9039 9052 16940516 10.1128/JVI.01013-06
12. An investigation of incorporation of cellular antigens into vaccinia virus particles. O Krauss R Hollinshead M Hollinshead GL Smith, J Gen Virol 2002 83 2347 2359 12237415
13. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. A Vanderplasschen E Mathew M Hollinshead RB Sim GL Smith, Proc Natl Acad Sci U S A 1998 95 7544 7549 9636186 10.1073/pnas.95.13.7544
14. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. JW Bess Jr. RJ Gorelick WJ Bosche LE Henderson LO Arthur, Virology 1997 230 134 144 10.1006/viro.1997.8499 9126269
15. Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. P Gluschankof I Mondor HR Gelderblom QJ Sattentau, Virology 1997 230 125 133 10.1006/viro.1997.8453 9126268
16. Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions. M Dettenhofer XF Yu, J Virol 1999 73 1460 1467 9882352
17. Passive and active inclusion of host proteins in human immunodeficiency virus type 1 gag particles during budding at the plasma membrane. M Hammarstedt H Garoff, J Virol 2004 78 5686 5697 15140966 10.1128/JVI.78.11.5686-5697.2004
18. Minimal exclusion of plasma membrane proteins during retroviral envelope formation. M Hammarstedt K Wallengren KW Pedersen N Roos H Garoff, Proc Natl Acad Sci U S A 2000 97 7527 7532 10852949 10.1073/pnas.120051597
19. Variations in the replication and antigenic properties of human herpesvirus 6 strains. LS Wyatt N Balachandran N Frenkel, J Infect Dis 1990 162 852 857 2169499
20. Purification of biologically active Epstein-Barr virus by affinity chromatography and non-ionic density gradient centrifugation. E Fowler N Raab-Traub S Hester, J Virol Methods 1985 11 59 74 10.1016/0166-0934(85)90125-9 2989311
21. Purification of equine herpesvirus type 1. WC Lawrence, J Gen Virol 1976 31 81 91 177732
22. Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. PG Spear B Roizman, J Virol 1972 9 143 159 4110104
23. Human cytomegalovirus. I. Purification and characterization of viral DNA. ES Huang ST Chen JS Pagano, J Virol 1973 12 1473 1481 4128379
24. Human cytomegalovirus: purification of enveloped virions and dense bodies. P Talbot JD Almeida, J Gen Virol 1977 36 345 349 197204
25. Principles and techniques of practical biochemistry. K Wilson J Walker,, Cambridge University Press 1994
26. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. SM Varnum DN Streblow ME Monroe P Smith KJ Auberry L Pasa-Tolic D Wang DG Camp 2nd K Rodland S Wiley W Britt T Shenk RD Smith JA Nelson, J Virol 2004 78 10960 10966 15452216 10.1128/JVI.78.20.10960-10966.2004
27. Proteins of purified Epstein-Barr virus. E Johannsen M Luftig MR Chase S Weicksel E Cahir-McFarland D Illanes D Sarracino E Kieff, Proc Natl Acad Sci U S A 2004 101 16286 16291 15534216 10.1073/pnas.0407320101
28. Virion proteins of Kaposi's sarcoma-associated herpesvirus. FX Zhu JM Chong L Wu Y Yuan, J Virol 2005 79 800 811 15613308 10.1128/JVI.79.2.800-811. 2005
29. Virion and nonstructural polypeptides of human herpesvirus-6. K Shiraki T Okuno K Yamanishi M Takahashi, Virus Res 1989 13 173 178 10.1016/0168-1702(89) 90014-2 2773596
30. Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. M Takemoto M Koike Y Mori S Yonemoto Y Sasamoto K Kondo Y Uchiyama K Yamanishi, J Virol 2005 79 13037 13046 16189006 10.1128/JVI.79.20.13037-13046.2005
31. CD46 is a cellular receptor for human herpesvirus 6. F Santoro PE Kennedy G Locatelli MS Malnati EA Berger P Lusso, Cell 1999 99 817 827 10.1016/S0092-8674(00)81678-5 10619434
32. Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients. A Fogdell-Hahn SS Soldan S Shue N Akhyani H Refai J Ahlqvist S Jacobson, Virus Res 2005 110 57 63 10.1016/j.virusres.2005.01.005 15845255
33. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. M Saifuddin T Hedayati JP Atkinson MH Holguin CJ Parker GT Spear, J Gen Virol 1997 78 ( Pt 8) 1907 1911 9266986
34. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). GT Spear NS Lurain CJ Parker M Ghassemi GH Payne M Saifuddin, J Immunol 1995 155 4376 4381 7594597
35. Autoimmunity caused by host cell protein-containing viruses. O Rott S Herzog E Cash, Med Microbiol Immunol 1994 183 4 195 204 10.1007/BF00194172 7531273
36. Mechanisms in the pathogenesis of post-infectious vaccinia virus encephalomyelitis in the mouse. R Tschannen AJ Steck R Schafer, Neurosci Lett 1979 15 295 300 10.1016/0304-3940(79)96129-9 93731
37. Human herpesvirus 6 infection in neoplastic and normal brain tissue. L Cuomo P Trivedi MR Cardillo FM Gagliardi A Vecchione R Caruso A Calogero L Frati A Faggioni G Ragona, J Med Virol 2001 63 45 51 10.1002/1096-9071(200101)63: 1<45::AID-JMV1006>3.0.CO;2-K 11130886
38. Complete replication cycle and acquisition of tegument in nucleus of human herpesvirus 6A in astrocytes and in T-cells. J Ahlqvist D Donati E Martinelli N Akhyani J Hou EO Major S Jacobson A Fogdell-Hahn, J Med Virol 2006 78 1542 1553 10.1002/jmv.20737 17063514
39. A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale. B Bjellqvist C Pasquali F Ravier JC Sanchez D Hochstrasser, Electrophoresis 1993 14 1357 1365 10.1002/elps.11501401209 8137802
40. Targeting of Moloney murine leukemia virus gag precursor to the site of virus budding. M Suomalainen K Hultenby H Garoff, J Cell Biol 1996 135 1841 1852 10.1083/jcb.135.6.1841 8991095